Risk of Inaccurate Results with Thermo Fisher Scientific TaqPath COVID-19 Combo Kit – Letter to Clinical Laboratory Staff and Health Care Providers

The FDA is alerting clinical laboratory staff and health care providers of a risk of inaccurate results with Thermo Fisher Scientific TaqPath COVID-19 Combo Kit.
Tags: No tags

Comments are closed.